Skin disorder caused by infection
Therapeutic area
Dermatology
Rare disease
No
- Definition
- Skin diseases caused by bacteria, fungi, parasites, or viruses.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Skin disorder caused by infection
- Therapeutic area
- Dermatology
- skin disorder caused by infection
- disease, infectious skin
- diseases, infectious skin
- infectious skin disease
- infectious skin diseases
- skin disease, infectious
- Disease mechanisms
- Acquired
- Severity
- Moderate
- Dermatology
- Infectious Disease
- MONDO ID
- MONDO:0024294
- Parent condition
- MONDO:0005093
Related records
Broader conditions (8)
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Infectious disease
- Integumentary system disorder
- Skin disorder
Narrower conditions (107)
- Anaerobic cellulitis
- Aquarium granuloma
- Bacillary angiomatosis
- Bacterial exanthem
- Bullous impetigo
- Cavitary myiasis
- Cellulitis
- Cercarial dermatitis
- Chalazion
- Chickenpox
- Chronic fungal otitis externa
- Common wart
- Conidiobolomycosis
- Creeping myiasis
- Cutaneous anthrax
- Cutaneous candidiasis
- Cutaneous diphtheria
- Cutaneous leishmaniasis
- Cutaneous myiasis
- Cutaneous syphilis
Trials (45)
- A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
- A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
- A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin
- A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin
- A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica.
- A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
- An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis
- AUGMENTIN 1gm In Skin And Soft Tissue Infection
- Cantharidin and Occlusion in Verruca Epithelium
- Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
- Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
- Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
- Dalbavancin in Real Clinical Practice in Spain
- Effect of an Antiseptic Solution on the Skin Microbiome
- Effect of Chlorhexidine Skin Cleansing on Skin Flora
- Effective Antibiotic Treatment of MRSA
- Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections
- Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)
- Emodepside Phase II Trial for Treatment of Onchocerciasis
- First in Man Clinical Trial of Emodepside (BAY 44-4400)
Approved drugs (2)
- Ceftaroline fosamil acetate
- Tigecycline